The Role of Monoclonal Antibody in Combination with First-Line Chemotherapy in Asian Patients with Advanced Non-Small Cell Lung Cancer

The strategies of incorporating monoclonal antibodies (MoABs) have now proved efficacy in the first-line treatment of advanced non-small cell lung cancer (NSCLC). These include targeting the vascular endothelial growth factor (VEGF) or epidermal growth factor receptor (EGFR). Bevacizumab is a MoAB t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Byoung Chul, Kim, Joo Hang, Soo, Ross A, Yang, Chih-Hsin
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799980/
https://www.ncbi.nlm.nih.gov/pubmed/20046507
http://dx.doi.org/10.3349/ymj.2010.51.1.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799980/
https://www.ncbi.nlm.nih.gov/pubmed/20046507
http://dx.doi.org/10.3349/ymj.2010.51.1.1

Ejemplares similares